Ambrx Biopharma, Inc. (AMAM)

NYSE: AMAM · IEX Real-Time Price · USD
3.85
-0.15 (-3.75%)
May 20, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Revenue
7.4613.6710.31
Revenue Growth (YoY)
-45.47%32.59%-
Gross Profit
7.4613.6710.31
Selling, General & Admin
17.076.356.4
Research & Development
54.8120.4326.38
Operating Expenses
71.8826.7932.78
Operating Income
-64.42-13.12-22.47
Other Expense / Income
3.653.43-2.41
Pretax Income
-68.08-16.54-20.06
Income Tax
00-0
Net Income
-68.08-16.54-20.06
Net Income Common
-68.08-16.54-20.06
Shares Outstanding (Basic)
143116136
Shares Outstanding (Diluted)
143116136
Shares Change
23.77%-15.01%-
EPS (Basic)
-3.36-0.98-1.05
EPS (Diluted)
-3.36-0.98-1.05
Free Cash Flow Per Share
-2.28-1.26-0.14
Gross Margin
100.00%100.00%100.00%
Operating Margin
-864.17%-95.93%-217.94%
Profit Margin
-913.20%-121.01%-194.57%
Free Cash Flow Margin
-625.03%-152.35%-27.28%
Effective Tax Rate
-0.00%-0.01%0.01%
EBITDA
-64.34-13.12-16.53
EBITDA Margin
-863.07%-95.98%-160.35%
EBIT
-68.08-16.54-20.06
EBIT Margin
-913.19%-121.00%-194.59%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).